ZENAS BIOPHARMA INC (ZBIO) Stock Cash Flow
NASDAQ:ZBIO - Nasdaq - US98937L1052 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -162.76M | -156.99M | -37.12M | -119.28M | |||
| Depreciation Amortization | 127.00K | 137.00K | 113.00K | 78.00K | |||
| Change In Working Capital | 9.71M | 25.43M | -8.04M | 7.97M | |||
| Other non cash items | 15.30M | 11.75M | 14.52M | 45.59M | |||
| OPERATING CASH FLOW | -137.62M | -119.67M | -30.53M | -65.65M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | -127.00K | -131.00K | -17.00K | -2.20M | |||
| Other Investing Activity | N/A | -30.42M | N/A | N/A | |||
| INVESTING CASH FLOW | -116.80M | -30.55M | -17.00K | -2.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | N/A | N/A | 20.00M | 0.00 | |||
| Stock Issued/Repurchased | 419.35M | 419.29M | 116.00K | 59.39M | |||
| Other Financing Activity | N/A | -6.33M | N/A | N/A | |||
| FINANCING CASH FLOW | 413.67M | 412.96M | 20.12M | 59.39M | |||
| Exchange Rate Effect | 69.00K | 157.00K | 78.00K | -41.00K | |||
| CHANGE IN CASH | 159.31M | 262.89M | -10.35M | -8.50M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -137.62M | -119.67M | -30.53M | -65.65M | |||
| Capital Expenditure | -127.00K | -131.00K | -17.00K | -2.20M | |||
| FREE CASH FLOW | -137.75M | -119.81M | -30.55M | -67.85M | |||
All data in USD